RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:RFL - US75062E1064 - Common Stock
RFL Key Statistics, Chart & Performance
The current stock price of RFL is 1.49 USD. In the past month the price increased by 17.32%. In the past year, price decreased by -20.74%.
RFL Latest News, Press Relases and Analysis
RFL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.9 | 954.25B | ||
| JNJ | JOHNSON & JOHNSON | 20.23 | 505.98B | ||
| MRK | MERCK & CO. INC. | 11.24 | 245.74B | ||
| PFE | PFIZER INC | 8.06 | 146.69B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.8 | 104.23B | ||
| ZTS | ZOETIS INC | 18.56 | 51.85B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.44 | 22.40B | ||
| VTRS | VIATRIS INC | 4.97 | 13.35B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.16 | 10.57B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.01 | 9.17B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.50B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.24B |
Related stock screener links
About RFL
Company Profile
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. The firm holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. The company also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. The company holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
Company Info
RAFAEL HOLDINGS INC-CLASS B
520 Broad Street
Newark NEW JERSEY 07102 US
CEO: Ameet Mallik
Employees: 28
Phone: 12126581450
RAFAEL HOLDINGS INC-CLASS B / RFL FAQ
What does RAFAEL HOLDINGS INC-CLASS B do?
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. The firm holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. The company also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. The company holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
What is the current price of RFL stock?
The current stock price of RFL is 1.49 USD. The price decreased by -2.61% in the last trading session.
What is the dividend status of RAFAEL HOLDINGS INC-CLASS B?
RFL does not pay a dividend.
What is the ChartMill rating of RAFAEL HOLDINGS INC-CLASS B stock?
RFL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is RAFAEL HOLDINGS INC-CLASS B (RFL) stock traded?
RFL stock is listed on the New York Stock Exchange exchange.
What is the market capitalization of RFL stock?
RAFAEL HOLDINGS INC-CLASS B (RFL) has a market capitalization of 77.12M USD. This makes RFL a Micro Cap stock.
RFL Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to RFL. When comparing the yearly performance of all stocks, RFL is a bad performer in the overall market: 70.83% of all stocks are doing better.
RFL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RFL. While RFL seems to be doing ok healthwise, there are quite some concerns on its profitability.
RFL Financial Highlights
Over the last trailing twelve months RFL reported a non-GAAP Earnings per Share(EPS) of -1.03. The EPS increased by 27.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.75% | ||
| ROE | -32.34% | ||
| Debt/Equity | 0.01 |